Home > Portfolio > Actimis Pharmaceuticals
Portfolio Companies

Actimis Pharmaceuticals (Acquired by Boehringer Ingelheim)

URL: http://www.actimis.com/
Domain: Healthcare
Area: United States

Actimis Pharmaceuticals is a private pharmaceutical company based in California focusing on inflammatory diseases.

Company Actimis Pharmaceuticals
URL http://www.actimis.com/

News Release

[06/17/2008]

Boehringer Ingelheim to acquire Actimis Pharmaceuticals

Boehringer Ingelheim GmbH today announced an agreement to acquire Actimis Pharmaceuticals, Inc. The acquisition will occur through a structured buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the achievement of several successive milestones with Actimis' leading asthma compound AP768.

[04/28/2005]

Bayer Healthcare AG Spin-out, Actimis Pharmaceuticals, Completes $6 Million Series A Financing

San Diego, CA, April 28, 2005 - Actimis Pharmaceuticals, Inc., a startup company dedicated to developing and commercializing small molecule therapeutics for respiratory and inflammatory diseases, today announced a $6 million private placement ...

Portfolio Companies
  • United States
  • Japan
  • China
  • Other
  • United States
  • Japan
  • China
  • United States
  • Japan
  • United States
  • China

News Release

09/27/2010 11/01/2010
MVC Corporation Changes Name to Mitsui & Co. Global Investment, Ltd. 09/27/2010 11/01/2010
MCVP Changes Name and Relocates Office 09/27/2010 09/27/2010
Notice on Relocation of MVC Head Office 09/24/2010 09/24/2010
Mitsui Ventures invested USD 5 M in S*BIO Taro Inaba 06/17/2008 | Taro Inaba
Boehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.